ID: ALA208058

Max Phase: Preclinical

Molecular Formula: C28H36O6

Molecular Weight: 468.59

Molecule Type: Small molecule

Representations

Canonical SMILES:  C=C1CC[C@@H]2[C@]3(C)COC(c4ccccc4OC)O[C@@H]3CC[C@@]2(C)[C@@H]1C/C=C1/C(=O)OC[C@H]1O

Standard InChI:  InChI=1S/C28H36O6/c1-17-9-12-23-27(2,20(17)11-10-18-21(29)15-32-25(18)30)14-13-24-28(23,3)16-33-26(34-24)19-7-5-6-8-22(19)31-4/h5-8,10,20-21,23-24,26,29H,1,9,11-16H2,2-4H3/b18-10+/t20-,21-,23+,24-,26?,27+,28+/m1/s1

Standard InChI Key:  FLJJUUNTCCLOAK-BDMHOTNUSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 468.59

Molecular Weight (Monoisotopic): 468.2512

AlogP: 4.73

#Rotatable Bonds: 4

Polar Surface Area: 74.22

Molecular Species: NEUTRAL

HBA: 6

HBD: 1

#RO5 Violations: 0

HBA (Lipinski): 6

HBD (Lipinski): 1

#RO5 Violations (Lipinski): 0

CX Acidic pKa: 13.52

CX Basic pKa:

CX LogP: 4.67

CX LogD: 4.67

Aromatic Rings: 1

Heavy Atoms: 34

QED Weighted: 0.39

Np Likeness Score: 2.47

References

1. Dai GF, Xu HW, Wang JF, Liu FW, Liu HM..  (2006)  Studies on the novel alpha-glucosidase inhibitory activity and structure-activity relationships for andrographolide analogues.,  16  (10): [PMID:16504503] [10.1016/j.bmcl.2006.02.011]

Source

Source(1):

• Scientific Literature